The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
Open accessAbstract
// Christine Mehner 1 , Alexandra Hockla 1 , Erin Miller 1 , Sophia Ran 2 , Derek C. Radisky 1,* and Evette S. Radisky 1,* 1 Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 2 Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, IL Correspondence: Evette S. Radisky, email: // Derek C. Radisky, email: // Keywords : triple negative breast cancer, basal-like breast cancer, matrix metalloproteinases, invasion, metastasis, mouse orthotopic tumor models, bioluminescence imaging Received : March 3, 2014 Accepted : April 30, 2014 Published : May 1, 2014 Abstract Matrix metalloproteinases (MMPs) have been implicated in diverse roles in breast cancer development and progression. While many of the different MMPs expressed in breast cancer are produced by stromal cells MMP-9 is produced mainly by the tumor cells themselves. To date, the functional role of tumor cell-produced MMP-9 has remained unclear. Here, we show that human breast cancer cell-produced MMP-9 is specifically required for invasion in cell culture and for pulmonary metastasis in a mouse orthotopic model of basal-like breast cancer. We also find that tumor cell-produced MMP-9 promotes tumor vascularization with only modest impact on primary tumor growth, and that silencing of MMP-9 expression in tumor cells leads to an altered transcriptional program consistent with reversion to a less malignant phenotype. MMP-9 is most highly expressed in human basal-like and triple negative tumors, where our data suggest that it contributes to metastatic progression. Our results suggest that MMP9 may offer a target for anti-metastatic therapies for basal-like triple negative breast cancers, a poor prognosis subtype with few available molecularly targeted therapeutic options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Triple-negative breast cancer: clinical features and patterns of recurrence
Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., & Narod, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3045 · Cited by 5,091
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797 · cited 1×
“MMP9 has been implicated previously as a critical mediator in the processes of tumor angiogenesis and vasculogenesis [32, 33], and so we also assessed the extent of tumor vascularization by staining the tumors for endothelial cell marker CD31.”
MethodMatrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
Breast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
The molecular portraits of breast tumors are conserved across microarray platforms
Hu, Z., Fan, C., Oh, D. S., Marron, J., He, X., Qaqish, B. F., Livasy, C., Carey, L. A., Reynolds, E., Dressler, L., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-96 · Cited by 1,491
Miller, L. D., Smeds, J., George, J., Vega, V. B., Vergara, L., Ploner, A., Pawitan, Y., Hall, P., Klaar, S., Liu, E. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506230102 · Cited by 1,268
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Extracellular matrix remodelling: the role of matrix metalloproteinases
Stamenkovic, I. (2003) · The Journal of Pathology · doi:10.1002/path.1400 · Cited by 1,140
Blows, F. M., Driver, K. E., Schmidt, M. K., Broeks, A., van Leeuwen, F. E., Wesseling, J., Cheang, M. C., Gelmon, K., Nielsen, T. O., Blomqvist, C., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000279 · Cited by 1,116
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Silver, D. P., Richardson, A. L., Eklund, A. C., Wang, Z. C., Szallasi, Z., Li, Q., Juul, N., Leong, C.-O., Calogrias, D., Buraimoh, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4725 · Cited by 981
X chromosomal abnormalities in basal-like human breast cancer
Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., & Ganesan, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.013 · Cited by 869
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A., Pilch, H., Lehr, H.-A., Hengstler, J. G., Kölbl, H., & Gehrmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 836
Pawitan, Y., Bjöhle, J., Amler, L., Borg, A.-L., Egyhazi, S., Hall, P., Han, X., Holmberg, L., Huang, F., Klaar, S., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1325 · Cited by 831
Kao, J., Salari, K., Bocanegra, M., Choi, Y.-L., Girard, L., Gandhi, J., Kwei, K. A., Hernandez-Boussard, T., Wang, P., Gazdar, A. F., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006146 · Cited by 788
Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer
Ivshina, A. V., George, J., Senko, O., Mow, B., Putti, T. C., Smeds, J., Lindahl, T., Pawitan, Y., Hall, P., Nordgren, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4414 · Cited by 752
Yu, Q., & Stamenkovic, I. (1999) · Genes & Development · doi:10.1101/gad.13.1.35 · Cited by 713
Bauvois, B. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.001 · Cited by 543
Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
Radisky, E. S., & Radisky, D. C. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9177-x · Cited by 524
Self-citationAhn, G.-O., & Brown, J. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.11.032 · Cited by 432
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
Ringnér, M., Fredlund, E., Häkkinen, J., Borg, Å., & Staaf, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017911 · Cited by 418
Basal Breast Cancer: A Complex and Deadly Molecular Subtype
Bertucci, F., Finetti, P., & Birnbaum, D. (2012) · Current Molecular Medicine · doi:10.2174/156652412798376134 · Cited by 394
Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data
Kupershmidt, I., Su, Q. J., Grewal, A., Sundaresh, S., Halperin, I., Flynn, J., Shekar, M., Wang, H., Park, J., Cui, W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013066 · Cited by 368
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603043 · Cited by 340
Pellikainen, J. M., Ropponen, K. M., Kataja, V. V., Kellokoski, J. K., Eskelinen, M. J., & Kosma, V.-M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1061 · Cited by 339
André, F., & Zielinski, C. C. (2012) · Annals of Oncology · doi:10.1093/annonc/mds195 · Cited by 329
The other side of MMPs: Protective roles in tumor progression
Martin, M. D., & Matrisian, L. M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9089-4 · Cited by 311
Experimental metastasis is suppressed in MMP-9-deficient mice
Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., & Uehira, M. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006603723759 · Cited by 308
A refined molecular taxonomy of breast cancer
Guedj, M., Marisa, L., de Reynies, A., Orsetti, B., Schiappa, R., Bibeau, F., MacGrogan, G., Lerebours, F., Finetti, P., Longy, M., et al. (2012) · Oncogene · doi:10.1038/onc.2011.301 · Cited by 287
MMPs as therapeutic targets—Still a viable option?
FINGLETON, B. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.06.006 · Cited by 279
Matrix metalloproteinases: roles in cancer and metastasis
Fingleton, B. (2006) · Frontiers in Bioscience · doi:10.2741/1811 · Cited by 271
Study of matrix metalloproteinases and their inhibitors in breast cancer
Vizoso, F. J., González, L. O., Corte, M. D., Rodríguez, J. C., Vázquez, J., Lamelas, M. L., Junquera, S., Merino, A. M., & García-Muñiz, J. L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603666 · Cited by 271
Bourguignon, L. Y. W., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J. T., Muller, W. J., & Cardiff, R. D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<206::aid-jcp22>3.0.co;2-3 · Cited by 270
Sparano, J. A., Bernardo, P., Stephenson, P., Gradishar, W. J., Ingle, J. N., Zucker, S., & Davidson, N. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.054 · Cited by 269
Prognostic significance of MMP‐9 and TIMP‐1 serum and tissue expression in breast cancer
Wu, Z., Wu, Q., Yang, J., Wang, H., Ding, X., Yang, F., & Xu, X. (2008) · International Journal of Cancer · doi:10.1002/ijc.23337 · Cited by 268
Scorilas, A., Karameris, A., Arnogiannaki, N., Ardavanis, A., Bassilopoulos, P., Trangas, T., & Talieri, M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1810 · Cited by 258
Predicting features of breast cancer with gene expression patterns
Lu, X., Lu, X., Wang, Z. C., Iglehart, J. D., Zhang, X., & Richardson, A. L. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9596-6 · Cited by 241
Glück, S., Ross, J. S., Royce, M., McKenna, E. F., Perou, C. M., Avisar, E., & Wu, L. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1412-7 · Cited by 229
DNA methylation profiling reveals a predominant immune component in breast cancers
Dedeurwaerder, S., Desmedt, C., Calonne, E., Singhal, S. K., Haibe‐Kains, B., Defrance, M., Michiels, S., Volkmar, M., Deplus, R., Luciani, J., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100801 · Cited by 225
Recent advances in MMP inhibitor design
Fisher, J. F., & Mobashery, S. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7894-9 · Cited by 215
Tabchy, A., Valero, V., Vidaurre, T., Lluch, A., Gomez, H., Martin, M., Qi, Y., Barajas-Figueroa, L. J., Souchon, E., Coutant, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1265 · Cited by 210
Matrix metalloproteinases: protective roles in cancer
Decock, J., Thirkettle, S., Wagstaff, L., & Edwards, D. R. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01302.x · Cited by 205
Li, H.-C., Cao, D.-C., Liu, Y., Hou, Y.-F., Wu, J., Lu, J.-S., Di, G.-H., Liu, G., Li, F.-M., Ou, Z.-L., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-1200-8 · Cited by 181
Zhang, H., Meng, F., Liu, G., Zhang, B., Zhu, J., Wu, F., Ethier, S. P., Miller, F., & Wu, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2825 · Cited by 177
Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective
Penault-Llorca, F., & Viale, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds190 · Cited by 171
Genome profiling of ERBB2-amplified breast cancers
Sircoulomb, F., Bekhouche, I., Finetti, P., Adélaïde, J., Hamida, A. B., Bonansea, J., Raynaud, S., Innocenti, C., Charafe-Jauffret, E., Tarpin, C., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-539 · Cited by 167
McGowan, P. M., & Duffy, M. J. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn180 · Cited by 165
Sela-Passwell, N., Rosenblum, G., Shoham, T., & Sagi, I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.010 · Cited by 160
Role of the hemopexin domain of matrix metalloproteinases in cell migration
Dufour, A., Sampson, N. S., Zucker, S., & Cao, J. P. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21535 · Cited by 159
Sela-Passwell, N., Kikkeri, R. V., Dym, O., Rozenberg, H., Margalit, R., Arad‐Yellin, R., Eisenstein, M., Brenner, O. J., Shoham, T., Danon, T., et al. (2011) · Nature Medicine · doi:10.1038/nm.2582 · Cited by 158
Cell surface association of matrix metalloproteinase-9 (gelatinase B)
Fridman, R. A., Tóth, M., Chvyrkova, I., Meroueh, S. O., & Mobashery, S. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023091214123 · Cited by 155
Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer
Sabatier, R., Finetti, P., Adélaı̈de, J., Guillé, A., Borg, J., Chaffanet, M., Lane, L., Birnbaum, D., & Bertucci, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027656 · Cited by 154
Molecularly targeted therapies for metastatic triple-negative breast cancer
Bayraktar, S., & Glück, S. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2421-5 · Cited by 147
Role of Matrix Metalloproteinase-9 Dimers in Cell Migration
Dufour, A., Zucker, S., Sampson, N. S., Kuscu, C., & Cao, J. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091769 · Cited by 147
Potent Mechanism-based Inhibitors for Matrix Metalloproteinases
Ikejiri, M., Bernardo, M. M., Bonfil, R. D., Tóth, M., Chang, M., Fridman, R. A., & Mobashery, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504303200 · Cited by 136
Martin, M. D., Carter, K. J., Jean-Philippe, S. R., Chang, M., Mobashery, S., Thiolloy, S., Lynch, C. C., Matrisian, L. M., & Fingleton, B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0537 · Cited by 134
Dufour, A., Sampson, N. S., Li, J., Kuscu, C., Rizzo, R. C., DeLeon, J. L., Zhi, J., Jaber, N. L., Liu, E. V., Zucker, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4552 · Cited by 131
Antimetastatic Activity of a Novel Mechanism-Based Gelatinase Inhibitor
Krüger, A., Arlt, M., Gerg, M., Kopitz, C., Bernardo, M. M., Chang, M., Mobashery, S., & Fridman, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3570 · Cited by 127
Stromal induction of breast cancer: Inflammation and invasion
Radisky, E. S., & Radisky, D. C. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9037-1 · Cited by 126
Self-citationBatra, J., Robinson, J., Soares, A. S., Fields, A. P., Radisky, D. C., & Radisky, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.341156 · Cited by 120
Self-citationLü, X., & Kang, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900108106 · Cited by 120
Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression
Stallings‐Mann, M. L., Waldmann, J., Zhang, Y., Miller, E. E., Gauthier, M. L., Visscher, D. W., Downey, G. P., Radisky, E. S., Fields, A. P., & Radisky, D. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004062 · Cited by 111
Self-citationRecombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer
Li, H., Zhang, C., Qiu, Y., Wang, L., Luo, Y., Jin, M., Zhang, Y., Guo, T. B., Matsushima, K., & Zhang, Y. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.01.005 · Cited by 109
Martens, E., Leyssen, A., Aelst, I. V., Fiten, P., Piccard, H., Hu, J., Descamps, F. J., den Steen, P. E. V., Proost, P., Damme, J. V., et al. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.10.012 · Cited by 93
Acuff, H. B., Sinnamon, M. J., Fingleton, B., Boone, B. E., Levy, S., Chen, X., Pozzi, A., Carbone, D. P., Schwartz, D. R., Moin, K., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4279 · Cited by 92
Selective Modulation of Matrix Metalloproteinase 9 (MMP-9) Functions via Exosite Inhibition
Lauer‐Fields, J. L., Whitehead, J. K., Li, S., Hammer, R. P., Brew, K., & Fields, G. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801438200 · Cited by 85
A Randomized Phase II Feasibility Trial of BMS-275291 in Patients with Early Stage Breast Cancer
Miller, K. D., Saphner, T. J., Waterhouse, D. M., Chen, T., Rush-Taylor, A., Sparano, J. A., Wolff, A. C., Cobleigh, M., Galbraith, S. M., & Sledge, G. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0968 · Cited by 83
Björklund, M., Heikkilä, P., & Koivunen, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401601200 · Cited by 81
The development of endocrine therapy for women with breast cancer
Sainsbury, R. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.07.006 · Cited by 79
Hamze, A. B., Wei, S., Bahudhanapati, H., Kota, S., Acharya, K. R., & Brew, K. (2007) · Protein Science · doi:10.1110/ps.072978507 · Cited by 78
PRSS3/Mesotrypsin Is a Therapeutic Target for Metastatic Prostate Cancer
Hockla, A., Miller, E. E., Salameh, M. A., Copland, J. A., Radisky, D. C., & Radisky, E. S. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0314 · Cited by 71
Self-citationBatra, J., Robinson, J., Mehner, C., Hockla, A., Miller, E. E., Radisky, D. C., & Radisky, E. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050028 · Cited by 66
Self-citationStefanidakis, M., Björklund, M., Ihanus, E., Gahmberg, C. G., & Koivunen, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302288200 · Cited by 65
Unraveling Hidden Regulatory Sites in Structurally Homologous Metalloproteases
Udi, Y., Fragai, M., Grossman, M., Mitternacht, S., Arad‐Yellin, R., Calderone, V., Melikian, M., Toccafondi, M., Berezovsky, I. N., Luchinat, C., et al. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.04.009 · Cited by 64
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer
Miller, K. D., Gradishar, W. J., Schuchter, L. M., Sparano, J. A., Cobleigh, M., Robert, N. J., Rasmussen, H. S., & Sledge, G. W. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf199 · Cited by 64
Batra, J., Soares, A. S., Mehner, C., & Radisky, E. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075836 · Cited by 47
Self-citationCichon, M. A., Gainullin, V. G., Zhang, Y., & Radisky, D. C. (2011) · Integrative Biology · doi:10.1039/c1ib00090j · Cited by 42
Self-citationTissue Inhibitors of Metalloproteinases ( TIMPs ): Inhibition of Zn‐Dependent Metallopeptidases
Batra, J., & Radisky, E. S. (2014) · Wiley eBooks · doi:10.1002/9781119951438.eibc2168 · Cited by 8
Self-citation
Cited by
Parhi, L., Alon-Maimon, T., Sol, A., Nejman, D., Shhadeh, A., Fainsod-Levi, T., Yajuk, O., Isaacson, B., Abed, J., Maalouf, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16967-2 · Cited by 716
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
Huang, H. (2018) · Sensors · doi:10.3390/s18103249 · Cited by 739
Tumor-Associated Neutrophils in Cancer: Going Pro
Wu, L., Saxena, S., Awaji, M., & Singh, R. K. (2019) · Cancers · doi:10.3390/cancers11040564 · Cited by 337
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
Raeeszadeh-Sarmazdeh, M., Do, L., & Hritz, B. (2020) · Cells · doi:10.3390/cells9051313 · Cited by 324
The regulation of MMP targeting to invadopodia during cancer metastasis
Jacob, A., & Prekeris, R. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00004 · Cited by 299
Metadata
- Authors
- Mehner, C., Hockla, A., Miller, E., Ran, S., Radisky, D. C., & Radisky, E. S.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-05-01
- Volume
- 5
- Issue
- 9
- Pages
- 2736-2749
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2132799659
- Cited by
- 368
- References
- 91
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.